The Max Planck Institute for Psychiatry (MPIP; Director: Florian Holsboer, M.D., Ph.D.) is a clinical research institute which serves psychiatric inpatients and several outpatient clinics (e.g., lithium clinic, memory clinic, anxiety disorder clinic, neuroleptic clinic). Affiliated with the Krankenhaus München-Schwabing, the largest general hospital in Bavaria (approximately 1,400 beds), the MPIP provides neurological and psychiatric consultation services for this center. According to the scientific concept envisioned by the first director of the MPIP, Emil Kraepelin, the Clinical Institute runs numerous on-site, state-of-the-art laboratories for basic research (molecular biology, neuroendocrinology, neuropharmacology, electrophysiology, neuropsychology, brain imaging) in order to bridge the gap between preclinical and clinical scientific activities.